Response to influenza vaccine in people with non-protective HI antibody titers

被引:17
作者
Baldo, Vincenzo
Baldovin, Tatjana
Floreani, Annarosa
Minuzzo, Michele
Trivello, Renzo
机构
[1] Univ Padua, Dept Environm Med & Publ Hlth, Inst Hyg, I-35131 Padua, Italy
[2] Univ Padua, Dept Surg & Gastroenterol Sci, Padua, Italy
关键词
antibody response; influenza; MF59; vaccine;
D O I
10.1007/s10654-006-9071-4
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];
摘要
The purpose of the study was to determine which factors correlate directly with response to vaccination in such a group of subjects with non-protective HI antibody titers before vaccination. Two vaccines were used, a subunit virus vaccine adjuvanted with MF59 and a split virus vaccine. The analysis indicated that immunization with vaccine adjuvanted with MF59 was an independent variable for immune response against A/H3N2 (OR: 3.51; 95% CI: 1.81-6.79) and B (OR: 2.31; 95% CI: 1.37-3.89). The results suggest that antibody response to vaccine is satisfactory in elderly people previously lacking a protective antibody titer, and that the adjuvanted vaccine reveals a better immunogenicity.
引用
收藏
页码:843 / 845
页数:3
相关论文
共 8 条
[1]
Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines - A review and meta-analysis of the literature [J].
Beyer, WEP ;
Palache, AM ;
Osterhaus, ADME .
CLINICAL DRUG INVESTIGATION, 1998, 15 (01) :1-12
[2]
Seroprotection rate, mean fold increase, seroconversion rate:: which parameter adequately expresses seroresponse to influenza vaccination? [J].
Beyer, WEP ;
Palache, AM ;
Lüchters, G ;
Nauta, J ;
Osterhaus, ADME .
VIRUS RESEARCH, 2004, 103 (1-2) :125-132
[3]
de Jong J C, 2003, Dev Biol (Basel), V115, P63
[4]
Influenza vaccines: Antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population [J].
Menegon, T ;
Baldo, V ;
Bonello, C ;
Costa, DD ;
Di Tommaso, A ;
Trivello, R .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1999, 15 (06) :573-576
[5]
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza [J].
Nicholson, KG ;
Colegate, AE ;
Podda, A ;
Stephenson, I ;
Wood, J ;
Ypma, E ;
Zambon, MC .
LANCET, 2001, 357 (9272) :1937-1943
[6]
A history of influenza [J].
Potter, CW .
JOURNAL OF APPLIED MICROBIOLOGY, 2001, 91 (04) :572-579
[7]
Dose-dependent antibody response to influenza H1N1 vaccine component in elderly nursing home patients [J].
Remarque, EJ ;
de Jong, JMA ;
van der Klis, RJ ;
Masurel, N ;
Lighthart, GJ .
EXPERIMENTAL GERONTOLOGY, 1999, 34 (01) :109-115
[8]
A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community [J].
Vu, T ;
Farish, S ;
Jenkins, M ;
Kelly, H .
VACCINE, 2002, 20 (13-14) :1831-1836